Valuation: Proteome Sciences plc

Market Cap 4.98M 6.58M 5.87M 5.48M 9.38M 637M 9.45M 65.79M 25.67M 324M 24.68M 24.17M 1.04B P/E 2024
-2.95x
P/E 2025 -2.4x
Enterprise Value 19.97M 26.39M 23.55M 21.98M 37.61M 2.55B 37.9M 264M 103M 1.3B 98.97M 96.9M 4.17B EV / Sales 2024
4.79x
EV / Sales 2025 5.96x
Free-Float
81.48%
Yield 2024 *
-
Yield 2025 -
1 day-2.41%
1 week-2.41%
Current month-2.41%
1 month+1.43%
3 months+1.43%
6 months-10.13%
Current year-43.20%
1 week 1.2
Extreme 1.2
1.7
1 month 1.11
Extreme 1.11
1.7
Current year 1.11
Extreme 1.11
4.4
1 year 1.11
Extreme 1.11
4.4
3 years 1.11
Extreme 1.11
7.5
5 years 1.11
Extreme 1.11
8.79
10 years 1.11
Extreme 1.11
11.25
Manager TitleAgeSince
Corporate Officer/Principal - 01/04/2017
Corporate Secretary - 01/08/2017
Director TitleAgeSince
Chairman 73 30/06/2014
Director/Board Member 62 01/01/2010
Director/Board Member 71 01/07/2014
Date Insider Type Main position Quantity % Market Cap. Importance
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
14/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
6/4/23
Vulpes Investment Management Pte Ltd.
BuyCompany 100,000 0.0339%
Change 5-day change 1-year change 3-year change Capi.($)
-2.41%-2.41%-18.86%-79.42% 6.78M
+0.58%-2.20%-26.18%+1.91% 170B
-1.81%-1.81%-13.13%+12.34% 111B
-1.01%-1.21%-24.81%+3.59% 107B
-0.03%+1.42%-46.89%-10.61% 75.95B
+0.28%+3.14%+3.91%+72.56% 60.37B
-0.65%+6.59%+11.44%+66.40% 53.53B
-0.08%-0.99%-6.16%-31.35% 49.11B
-1.70%-5.02%-19.29%+13.61% 40.6B
+1.09%-2.70%+27.03%+1.30% 31.47B
Average -0.29%+0.22%-11.29%+5.03% 69.9B
Weighted average by Cap. +0.06%-0.04%-16.46%+11.82%

Financials

2024 2025
Net sales 4.89M 6.46M 5.76M 5.38M 9.2M 625M 9.27M 64.55M 25.19M 318M 24.22M 23.71M 1.02B 3.76M 4.96M 4.43M 4.13M 7.07M 480M 7.13M 49.61M 19.36M 244M 18.61M 18.23M 784M
Net income -3.41M -4.5M -4.02M -3.75M -6.41M -435M -6.46M -44.99M -17.56M -221M -16.88M -16.53M -711M -3.06M -4.05M -3.61M -3.37M -5.77M -391M -5.81M -40.43M -15.78M -199M -15.17M -14.85M -639M
Net Debt 13.39M 17.7M 15.8M 14.74M 25.23M 1.71B 25.42M 177M 69.04M 871M 66.38M 64.99M 2.8B 14.99M 19.81M 17.68M 16.5M 28.23M 1.92B 28.45M 198M 77.26M 975M 74.29M 72.73M 3.13B
Projected Income Statement - Annual - Proteome Sciences plc
Logo Proteome Sciences plc
Proteome Sciences plc is a specialist provider of contract proteomics services. The Company’s services enable drug discovery, development and biomarker identification, and employs proprietary workflows for the optimum analysis of tissues, cells and body fluids. Its principal activities involve protein biomarker research and development. It uses high-sensitivity techniques to detect and characterize differentially expressed proteins in biological samples for diagnostic, prognostic and therapeutic applications. SysQuant and TMT MS2 are unbiased methods for identifying and contextualizing new targets and defining mechanisms of biological activity, while analysis using Super-Depletion and TMTcalibrator provides access to over 8,500 circulating plasma proteins for the discovery of disease-related biomarkers. In addition, it has invented and developed the technology for TMT and TMTpro, and manufactures these small, protein-reactive chemical reagents for multiplex quantitative proteomics.
Employees
32
Date Price Change Volume
07/10/26 GBX 1.420 -2.41% 10,410
06/10/26 GBX 1.455 +3.93% 4,527
05/10/26 GBX 1.400 -3.45% 9,103
02/10/26 GBX 1.450 0.00% 4,730
01/10/26 GBX 1.450 -0.34% 59,152